ClinicalTrials.gov also has a listing of clinical trials in HIV and many other types of studies
HIV Prevention Trials Network Studies. The GW Clinical Research Site conducts numerous studies of HIV prevention. Current studies underway include
HPTN 083, https://www.hptn.org/research/studies/hptn083, a Phase III study of injectable cabotegravir among cisgender men who have sex with men and transgender women who have sex with men.
HPTN 085, https://ampstudy.org/, a Phase II study of broadly neutralizing monoclonal antibodies (VRC01) as prevention against HIV acquisition.
For more information about available studies and eligibility criteria, please contact gwuphc@gwu.edu.
Whitman-Walker Health is a community health center that specializes in HIV/AIDS care and lesbian, gay, bisexual and transgender care. They have several research studies that look at new ways to prevent or treat diseases such as HIV and Hepatitis. There are several studies that are currently enrolling participants. This includes studies related to: New HIV medications, people looking to switch HIV medications, Hepatitis C treatment, Pre-Exposure Prophylaxis (PrEP) for HIV infection, HIV and heart health, HIV and probiotics, HIV and cognitive impairment, DC Cohort Longitudinal Study (a citywide study of HIV infection), and LGBTQ Health. If you are interested in joining any of these studies and would like more information, please explore the research information and details and complete the participation survey.